Nalaganje...
Minireview: Challenges and Opportunities in Development of PPAR Agonists
The clinical impact of the fibrate and thiazolidinedione drugs on dyslipidemia and diabetes is driven mainly through activation of two transcription factors, peroxisome proliferator-activated receptors (PPAR)-α and PPAR-γ. However, substantial differences exist in the therapeutic and side-effect pro...
Shranjeno v:
| izdano v: | Mol Endocrinol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Endocrine Society
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414793/ https://ncbi.nlm.nih.gov/pubmed/25148456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2013-1427 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|